These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 18985629)

  • 21. Progression-free survival remains debatable endpoint in cancer trials.
    Tuma R
    J Natl Cancer Inst; 2009 Nov; 101(21):1439-41. PubMed ID: 19828873
    [No Abstract]   [Full Text] [Related]  

  • 22. Natural products, both small and large, and a focus on cancer treatment.
    McAlpine J; Romano A; Ecker D
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):186-8. PubMed ID: 19333863
    [No Abstract]   [Full Text] [Related]  

  • 23. Common threads in cancer treatment.
    Herrington C; Wagner J; York A
    Clin J Oncol Nurs; 2009 Feb; 13(1):9-10. PubMed ID: 19193541
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of natural products on developing new anti-cancer agents.
    Cragg GM; Grothaus PG; Newman DJ
    Chem Rev; 2009 Jul; 109(7):3012-43. PubMed ID: 19422222
    [No Abstract]   [Full Text] [Related]  

  • 25. Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients.
    Rubio-Viqueira B; Hidalgo M
    Clin Pharmacol Ther; 2009 Feb; 85(2):217-21. PubMed ID: 19005462
    [No Abstract]   [Full Text] [Related]  

  • 26. Trial watch: pivotal oncology trials: outlook for Q2 2009.
    Nehring R
    Nat Rev Drug Discov; 2009 Apr; 8(4):266. PubMed ID: 19337264
    [No Abstract]   [Full Text] [Related]  

  • 27. Proton transport inhibitors as potentially selective anticancer drugs.
    Harguindey S; Arranz JL; Wahl ML; Orive G; Reshkin SJ
    Anticancer Res; 2009 Jun; 29(6):2127-36. PubMed ID: 19528473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of thrombosis in ambulatory patients with cancer.
    Rana P; Levine MN
    J Clin Oncol; 2009 Oct; 27(29):4885-8. PubMed ID: 19752331
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Front-line drug discovery system for cancer].
    Mizukami T
    Gan To Kagaku Ryoho; 2008 Dec; 35(13):2293-300. PubMed ID: 19098393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The use of peptide bioregulators for cancer prevention: results of 35 years of research experience and perspectives].
    Anisimov VN; Khavinson VKh
    Vopr Onkol; 2009; 55(3):291-304. PubMed ID: 19670728
    [No Abstract]   [Full Text] [Related]  

  • 31. Smac mimetics as new cancer therapeutics.
    Chen DJ; Huerta S
    Anticancer Drugs; 2009 Sep; 20(8):646-58. PubMed ID: 19550293
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular perspectives on the non-responder phenomenon.
    Jackson DB
    Drug Discov Today; 2009 Apr; 14(7-8):373-9. PubMed ID: 19200455
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydroxyurea and hydroxamic acid derivatives as antitumor drugs.
    Saban N; Bujak M
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):213-21. PubMed ID: 19350240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of the first chemotherapy course on the quality of life of cancer patients in Turkey.
    Turgay AS; Khorshid L; Eser I
    Cancer Nurs; 2008; 31(6):E19-23. PubMed ID: 18987504
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting the DNA damage response in cancer.
    Ljungman M
    Chem Rev; 2009 Jul; 109(7):2929-50. PubMed ID: 19545147
    [No Abstract]   [Full Text] [Related]  

  • 36. NFkappaB signaling in carcinogenesis and as a potential molecular target for cancer therapy.
    Shen HM; Tergaonkar V
    Apoptosis; 2009 Apr; 14(4):348-63. PubMed ID: 19212815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer care expands to include genetic testing.
    Johns Hopkins Med Lett Health After 50; 2009 Jan; 20(11):4-5. PubMed ID: 19408409
    [No Abstract]   [Full Text] [Related]  

  • 38. Vitamin E analogues as mitochondria-targeting compounds: from the bench to the bedside?
    Zhao Y; Neuzil J; Wu K
    Mol Nutr Food Res; 2009 Jan; 53(1):129-39. PubMed ID: 19072740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting of cancer energy metabolism.
    Rodríguez-Enríquez S; Marín-Hernández A; Gallardo-Pérez JC; Carreño-Fuentes L; Moreno-Sánchez R
    Mol Nutr Food Res; 2009 Jan; 53(1):29-48. PubMed ID: 19123180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial function as an emerging 'target of interest' for cancer treatment.
    Sausville EA
    Curr Opin Investig Drugs; 2009 Jun; 10(6):523-5. PubMed ID: 19513940
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.